CoreCap Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.01M Buy
33,707
+4,174
+14% +$867K 0.24% 85
2026
Q1
$6.24M Sell
29,533
-1,800
-6% -$388K 0.21% 102
2025
Q4
$6.44M Buy
31,333
+4,431
+16% +$834K 0.22% 75
2025
Q3
$4.22M Sell
26,902
-464
-2% -$71.7K 0.15% 133
2025
Q2
$4.6M Buy
27,366
+9
+0% +$1.34K 0.19% 99
2025
Q1
$3.77M Buy
27,357
+1,572
+6% +$200K 0.17% 119
2024
Q4
$3.05M Buy
25,785
+1,093
+4% +$128K 0.14% 142
2024
Q3
$2.73M Buy
24,692
+3,421
+16% +$358K 0.13% 163
2024
Q2
$2.09M Buy
21,271
+906
+4% +$92.3K 0.22% 98
2024
Q1
$2.28M Sell
20,365
-6,370
-24% -$687K 0.12% 168
2023
Q4
$2.69M Buy
26,735
+6,578
+33% +$653K 0.17% 119
2023
Q3
$1.75M Sell
20,157
-2,470
-11% -$223K 0.13% 159
2023
Q2
$2.14M Buy
+22,627
New +$1.91M 0.15% 124
2022
Q4
$1.92M Buy
25,036
+1,105
+5% +$84K 0.14% 134
2022
Q3
$1.6M Buy
23,931
+19,289
+416% +$1.22M 0.13% 139
2022
Q2
$243K Buy
+4,642
New +$264K 0.02% 471
2022
Q1
Sell
-736
Closed -$38K 769
2021
Q4
$38K Buy
+736
New +$36.1K ﹤0.01% 1087

Other funds holding CAH

CoreCap Advisors's CAH Position: Q2 2026 in Review

CoreCap Advisors increased its Cardinal Health (CAH) stake by 14% in Q2 2026, buying an estimated $867K and bringing the position to 33,707 shares worth $8.01M. The position accounts for 0.24% of the portfolio, ranked #85.

CoreCap Advisors first reported a position in CAH in Q4 2021 and has held it in 17 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • CoreCap Advisors held 33,707 shares of Cardinal Health worth $8.01M as of Q2 2026.
  • CoreCap Advisors bought 4,174 Cardinal Health shares in Q2 2026, an estimated $867K.
  • Cardinal Health made up 0.24% of CoreCap Advisors's portfolio in Q2 2026, its #85 holding.
  • CoreCap Advisors first reported a position in Cardinal Health in Q4 2021 and has held it in 17 quarters since.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.